ADHD and insomnia [3]

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 45, Issue 4, 2006, Pages 384-385

  Cortese, Samuele ^a,b   Lecendreux, Michel ^a   Mouren, Marie Christine ^a   Konofal, Eric ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; ANTIDEPRESSANT AGENT; CENTRAL STIMULANT AGENT; CLONIDINE; CYPROHEPTADINE; SEROTONIN ANTAGONIST;

ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; COMORBIDITY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERACTIVITY; INSOMNIA; LETTER; OPPOSITIONAL DEFIANT DISORDER; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP DISORDER; SYMPTOMATOLOGY; CHEMICALLY INDUCED DISORDER; NOTE;

ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CLONIDINE; CYPROHEPTADINE; FEMALE; HUMANS; METHYLPHENIDATE; RESTLESS LEGS SYNDROME; SEROTONIN ANTAGONISTS; SLEEP DISORDERS;

EID: 33646359677     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000199577.12145.bc     Document Type: Letter

References (3)

1. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003), Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 4:101-119
2. Cortese S, Konofal E, Lecendreux M et al. (2005), Restless legs syndrome and attention-deficit/hyperactivity disorder: a review of the literature. Sleep 28:1007-1013
3. Kratochvil CJ, Lake M, Pliszka SR, Walkup JT (2005), Pharmacological management of treatment induced insomnia in ADHD. J Am Acad Child Adolesc Psychiatry 44:449-450